LT3113782T - Vaisto tiekimo sistemos ir būdai, skirti šlapimo pūslės vėžio gydymui gemcitabinu - Google Patents

Vaisto tiekimo sistemos ir būdai, skirti šlapimo pūslės vėžio gydymui gemcitabinu

Info

Publication number: LT3113782T
Authority: LT; Lithuania
Prior art keywords: gemcitabine; treatment; methods; drug delivery; delivery systems
Prior art date: 2014-03-06

Application number

LTEPPCT/US2015/019262T

Other languages

English (en)

Inventor

Dennis GIESING

Heejin Lee

Karen Daniel

Original Assignee

Taris Biomedical Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2014-03-06

Filing date

2015-03-06

Publication date

2022-11-25

2015-03-06 Application filed by Taris Biomedical Llc filed Critical Taris Biomedical Llc

2022-11-25 Publication of LT3113782T publication Critical patent/LT3113782T/lt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Urology & Nephrology (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Gynecology & Obstetrics (AREA)
Reproductive Health (AREA)
Dermatology (AREA)
Neurosurgery (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Oil, Petroleum & Natural Gas (AREA)
Hematology (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Anesthesiology (AREA)
Heart & Thoracic Surgery (AREA)
Biochemistry (AREA)
Nanotechnology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Infusion, Injection, And Reservoir Apparatuses (AREA)
Media Introduction/Drainage Providing Device (AREA)

LTEPPCT/US2015/019262T 2014-03-06 2015-03-06 Vaisto tiekimo sistemos ir būdai, skirti šlapimo pūslės vėžio gydymui gemcitabinu LT3113782T (lt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201461949215P	2014-03-06	2014-03-06
PCT/US2015/019262 WO2015134911A1 (en)	2014-03-06	2015-03-06	Drug delivery systems and methods for treatment of bladder cancer with gemcitabine

Publications (1)

Publication Number	Publication Date
LT3113782T true LT3113782T (lt)	2022-11-25

Family

ID=52697553

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LTEPPCT/US2015/019262T LT3113782T (lt)	2014-03-06	2015-03-06	Vaisto tiekimo sistemos ir būdai, skirti šlapimo pūslės vėžio gydymui gemcitabinu

Country Status (21)

Country	Link
US (3)	US20150250717A1 (lt)
EP (2)	EP4124339A1 (lt)
JP (4)	JP6901858B2 (lt)
KR (1)	KR102338079B1 (lt)
CN (1)	CN106102751A (lt)
AU (4)	AU2015226901B2 (lt)
BR (1)	BR112016020381A8 (lt)
CA (1)	CA2939979C (lt)
DK (1)	DK3113782T3 (lt)
ES (1)	ES2930435T3 (lt)
HR (1)	HRP20221252T1 (lt)
HU (1)	HUE060704T2 (lt)
IL (2)	IL311410A (lt)
LT (1)	LT3113782T (lt)
MX (1)	MX2016011333A (lt)
PL (1)	PL3113782T3 (lt)
PT (1)	PT3113782T (lt)
RS (1)	RS63675B1 (lt)
RU (1)	RU2694902C1 (lt)
SG (2)	SG11201607342QA (lt)
WO (1)	WO2015134911A1 (lt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP6309009B2 (ja)	2012-08-31	2018-04-11	タリスバイオメディカルエルエルシー	前立腺の治療のための薬物送達システム及び方法
KR102503010B1 (ko)	2013-08-19	2023-02-24	타리스 바이오메디컬 엘엘씨	다중 유닛 약물 전달 장치 및 방법
DK3113782T3 (da) *	2014-03-06	2022-10-17	Taris Biomedical Llc	Lægemiddelleveringssystemer og fremgangsmåder til behandling af blærekræft med gemcitabin
EP3452053B1 (en) *	2016-05-06	2022-12-14	TARIS Biomedical LLC	Method of treating lower tract urothelial cancer
EP3658153A4 (en) *	2017-07-25	2021-04-21	TARIS Biomedical LLC	METHOD OF TREATMENT OF TUMOR METASTASIS
EP3706763A4 (en)	2017-11-08	2021-08-11	TARIS Biomedical LLC	METHODS OF TREATMENT AND MAINTENANCE THERAPY FOR BLADDER CANCER USING GEMCITABINE
BR112021001337A2 (pt)	2018-08-01	2021-04-20	Taris Biomedical Llc	métodos de tratamento de bexiga hiperativa usando tróspio
EP4039279A4 (en) *	2019-10-03	2023-11-01	Seikagaku Corporation	TRANSMUCOSAL MEDICINAL ACTIVE DELIVERY SYSTEM FOR THE BLADDER SUBMUCOSA
RU2713443C2 (ru) *	2019-11-01	2020-02-05	Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр радиологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ радиологии" Минздрава России)	Способ комбинированного лечения мышечно-инвазивного рака мочевого пузыря т3-т4 n0-+m0
CN112169066B (zh) *	2020-10-29	2023-05-12	安徽省立医院(中国科学技术大学附属第一医院)	具有控制器的连续缓释给药留置管
CN113616666A (zh) *	2021-08-24	2021-11-09	傅广波	膀胱黏膜下注射吉西他滨在治疗膀胱癌中的应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4111203A (en) *	1976-11-22	1978-09-05	Alza Corporation	Osmotic system with means for improving delivery kinetics of system
AU2003278881A1 (en) *	2002-09-23	2004-04-08	Microchips, Inc.	Micro-reservoir osmotic release systems and microtube array device
US7207982B2 (en) *	2003-03-31	2007-04-24	Alza Corporation	Osmotic pump with means for dissipating internal pressure
US8361490B2 (en) *	2004-09-16	2013-01-29	Theracoat Ltd.	Biocompatible drug delivery apparatus and methods
DK1933810T3 (da)	2005-08-11	2013-01-28	Childrens Medical Center	Intravesikal lægemiddelafgivelsesindretning og fremgangsmåde
EP2049139A4 (en) *	2006-04-24	2009-06-24	Gloucester Pharmaceuticals Inc	TREATMENT OF TUMORS EXPRESSING RAS
WO2009076547A2 (en)	2007-12-11	2009-06-18	Massachusetts Institute Of Technology	Implantable drug delivery device ant) methods for treatment of the bladder and other body vestcles or lumens
CA2733468C (en)	2008-08-09	2017-12-05	Massachusetts Institute Of Technology	Implantable drug delivery device and methods of treating male genitourinary and surrounding tissues
WO2010151896A1 (en)	2009-06-26	2010-12-29	Taris Biomedical, Inc.	Solid drug tablets for implantable drug delivery devices
US9017312B2 (en)	2009-09-10	2015-04-28	Taris Biomedical Llc	Implantable device for controlled drug delivery
US8721621B2 (en)	2009-09-10	2014-05-13	Taris Biomedical, Inc.	Systems and methods for deploying devices to genitourinary sites
DK2512581T3 (da)	2009-12-17	2021-03-29	Taris Biomedical Llc	Implanterbar indretning med intravesikal tolerance
WO2011089604A2 (en) *	2010-01-20	2011-07-28	Theracoat Ltd	Material and method for treating internal cavities
US20110218488A1 (en)	2010-03-05	2011-09-08	Taris Biomedical, Inc.	Systems and Methods for Implanting Devices in the Bladder and Other Genitourinary Sites
WO2012048104A1 (en)	2010-10-06	2012-04-12	Taris Biomedical, Inc.	Implantable drug delivery device with bladden retention feature
US8690840B2 (en)	2010-10-06	2014-04-08	Taris Biomedical, Inc.	Time-selective bioresorbable or collapsible drug delivery systems and methods
WO2012106714A1 (en) *	2011-02-04	2012-08-09	Taris Biomedical, Inc.	Implantable device for controlled release of low solubility drug
JP6309009B2 (ja) *	2012-08-31	2018-04-11	タリスバイオメディカルエルエルシー	前立腺の治療のための薬物送達システム及び方法
SG11201507134YA (en)	2013-03-15	2015-10-29	Taris Biomedical Llc	Drug delivery devices and methods for drug delivery
CN105163794B (zh) *	2013-03-15	2020-03-27	塔里斯生物医药公司	具有药物可渗透部件的药物递送装置和方法
KR102503010B1 (ko) *	2013-08-19	2023-02-24	타리스 바이오메디컬 엘엘씨	다중 유닛 약물 전달 장치 및 방법
CA2929554A1 (en) *	2013-11-05	2015-05-14	Taris Biomedical Llc	Osmotic drug delivery devices, kits, and methods
DK3113782T3 (da)	2014-03-06	2022-10-17	Taris Biomedical Llc	Lægemiddelleveringssystemer og fremgangsmåder til behandling af blærekræft med gemcitabin

2015
- 2015-03-06 DK DK15711373.9T patent/DK3113782T3/da active
- 2015-03-06 HR HRP20221252TT patent/HRP20221252T1/hr unknown
- 2015-03-06 SG SG11201607342QA patent/SG11201607342QA/en unknown
- 2015-03-06 IL IL311410A patent/IL311410A/en unknown
- 2015-03-06 JP JP2016555554A patent/JP6901858B2/ja active Active
- 2015-03-06 PT PT157113739T patent/PT3113782T/pt unknown
- 2015-03-06 EP EP22196596.5A patent/EP4124339A1/en active Pending
- 2015-03-06 ES ES15711373T patent/ES2930435T3/es active Active
- 2015-03-06 SG SG10202101978SA patent/SG10202101978SA/en unknown
- 2015-03-06 CA CA2939979A patent/CA2939979C/en active Active
- 2015-03-06 MX MX2016011333A patent/MX2016011333A/es unknown
- 2015-03-06 RS RS20220937A patent/RS63675B1/sr unknown
- 2015-03-06 US US14/641,009 patent/US20150250717A1/en not_active Abandoned
- 2015-03-06 LT LTEPPCT/US2015/019262T patent/LT3113782T/lt unknown
- 2015-03-06 HU HUE15711373A patent/HUE060704T2/hu unknown
- 2015-03-06 PL PL15711373.9T patent/PL3113782T3/pl unknown
- 2015-03-06 AU AU2015226901A patent/AU2015226901B2/en active Active
- 2015-03-06 EP EP15711373.9A patent/EP3113782B1/en active Active
- 2015-03-06 WO PCT/US2015/019262 patent/WO2015134911A1/en active Application Filing
- 2015-03-06 IL IL247347A patent/IL247347B1/en unknown
- 2015-03-06 BR BR112016020381A patent/BR112016020381A8/pt not_active Application Discontinuation
- 2015-03-06 RU RU2016136103A patent/RU2694902C1/ru active
- 2015-03-06 CN CN201580011259.9A patent/CN106102751A/zh active Pending
- 2015-03-06 KR KR1020167027303A patent/KR102338079B1/ko active IP Right Grant
2019
- 2019-10-04 JP JP2019184023A patent/JP7061595B2/ja active Active
2020
- 2020-08-12 AU AU2020217383A patent/AU2020217383B2/en active Active
2021
- 2021-11-11 JP JP2021183995A patent/JP7383681B2/ja active Active
- 2021-12-23 US US17/561,540 patent/US20220117886A1/en active Pending
2022
- 2022-07-07 US US17/811,296 patent/US20220347091A1/en active Pending
- 2022-08-08 AU AU2022215156A patent/AU2022215156B2/en active Active
2023
- 2023-11-08 JP JP2023190543A patent/JP2024009034A/ja active Pending
2024
- 2024-11-08 AU AU2024259822A patent/AU2024259822A1/en active Pending

Also Published As

Publication number	Publication date
JP7061595B2 (ja)	2022-04-28
DK3113782T3 (da)	2022-10-17
IL311410A (en)	2024-05-01
JP6901858B2 (ja)	2021-07-14
CA2939979A1 (en)	2015-09-11
JP7383681B2 (ja)	2023-11-20
PL3113782T3 (pl)	2023-01-23
ES2930435T3 (es)	2022-12-13
IL247347B1 (en)	2024-11-01
EP3113782B1 (en)	2022-09-28
AU2020217383A1 (en)	2020-09-03
BR112016020381A2 (pt)	2017-08-15
SG10202101978SA (en)	2021-04-29
JP2022022235A (ja)	2022-02-03
AU2015226901A1 (en)	2016-09-01
AU2020217383B2 (en)	2022-09-08
EP3113782A1 (en)	2017-01-11
US20220117886A1 (en)	2022-04-21
US20150250717A1 (en)	2015-09-10
NZ723303A (en)	2023-10-27
RS63675B1 (sr)	2022-11-30
JP2019218410A (ja)	2019-12-26
AU2015226901B2 (en)	2020-05-14
JP2017508749A (ja)	2017-03-30
WO2015134911A1 (en)	2015-09-11
RU2694902C1 (ru)	2019-07-18
EP4124339A1 (en)	2023-02-01
AU2022215156A1 (en)	2022-09-01
AU2022215156B2 (en)	2024-09-05
HUE060704T2 (hu)	2023-04-28
JP2024009034A (ja)	2024-01-19
BR112016020381A8 (pt)	2018-05-02
PT3113782T (pt)	2023-01-05
KR102338079B1 (ko)	2021-12-09
KR20160124425A (ko)	2016-10-27
US20220347091A1 (en)	2022-11-03
HRP20221252T1 (hr)	2022-12-09
IL247347A0 (en)	2016-11-30
AU2024259822A1 (en)	2024-11-28
CA2939979C (en)	2023-03-21
SG11201607342QA (en)	2016-10-28
MX2016011333A (es)	2016-12-07
CN106102751A (zh)	2016-11-09

Publication	Publication Date	Title
HK1250376A1 (zh)	2018-12-14	用於癌症的治療和診斷方法
HK1248773A1 (zh)	2018-10-19	用於癌症的治療和診斷方法
IL248730B (en)	2021-10-31	Drug delivery system and method of use
IL259735B (en)	2021-10-31	Systems and methods for controlled drug delivery pumps
IL247347A0 (en)	2016-11-30	Systems and methods for administering drugs to treat bladder cancer using gemcitabine
IL250436A0 (en)	2017-03-30	Medical pad systems and methods
EP3151913A4 (en)	2017-11-15	Systems and methods of treating a neurological disorder in a patient
SG11201608483PA (en)	2016-11-29	Drug delivery systems and related methods of use
SG11201701035SA (en)	2017-03-30	Cancer diagnosis and therapy
GB2537770B (en)	2017-09-13	Methods and processes for application of drug delivery polymeric coatings
IL253157A0 (en)	2017-08-31	Systems and methods for improving the transfer of molecules that encourage bone growth for bone restoration
SG11201605745VA (en)	2016-08-30	Targeting clptm1l for treatment and prevention of cancer
IL250814A0 (en)	2017-04-30	A drug release device and a container to store it
EP3157524A4 (en)	2017-12-06	Methods of treating cancer and preventing cancer drug resistance
GB201511159D0 (en)	2015-08-05	Controlled cell delivery vehicle and treatment of tumours
EP3169399A4 (en)	2018-03-14	Systems and methods for providing radiotherapy treatment
IL250637A0 (en)	2017-04-30	Targeted release of hydrophilic drugs
GB201410695D0 (en)	2014-07-30	Uses of oligouronates in cancer treatment